ctp synthase

CTP Synthetase-IN-1 is an orally active and potent cytidine 5'-triphosphate synthetase (CTPS) inhibitor with potential antitumour activity, shows anti-inflammatory activity in animal models of inflammation, inhibits human CTPS1 and human CTPS2, and can be used in studies of arthritis and rheumatoid arthritis.

CTP Synthetase-IN-1 Ammonium salt is an orally active and potent cytidine 5'-triphosphate synthetase (CTPS) inhibitor with potential antimicrobial, anti-inflammatory and antitumor activity for the study of SARS-CoV-2 viral infections.

CTPS1-IN-1 is a cytidine-5′ triphosphate synthase 1 (CTPS1) inhibitor with potential antitumor activity and can be used to study autoimmune diseases.

Cytidine-5'-triphosphate-13C,D1 dilithium is a deuterated and 13C labeled form of Cytidine-5'-triphosphate. This triphosphate nucleotide, known as Cytidine 5′-triphosphate (Cytidine triphosphate; 5'-CTP), serves as a building block for the synthesis of nucleotides, nucleic acids, and lipids. Cytidine 5′-triphosphate synthase catalyzes the conversion of UTP to 5'-CTP. It is also an essential biomolecule for T. gondii in its de novo pyrimidine biosynthesis pathway.

Cytidine-5′-triphosphate-D14 disodium isodium) is the deuterated form of Cytidine-5′-triphosphate disodium (T5288). Cytidine 5′-triphosphate (Cytidine triphosphate; 5'-CTP) is a triphosphate nucleotide and serves as a building block in nucleotide, nucleic acid, and lipid biosynthesis. The enzyme CTP synthase catalyzes the conversion of UTP to 5'-CTP. Cytidine 5′-triphosphate is an essential biomolecule in the de novo pyrimidine biosynthesis pathway of T. gondii.

Cyclopentenyl cytosine triphosphoric is an active intracellular metabolite of the antineoplastic nucleoside analogue cyclopentenyl cytosine (CPEC). It inhibits CTP synthase and depletes the cytidine nucleotide pool. Cyclopentenyl cytosine triphosphoric is used in cancer research, including studies on leukemia.